Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on VERTEX PHARMACEUTICALS INC
04/23 VERTEX PHARMACEUTICALS : Assigned Patent
04/22 VERTEX PHARMACEUTICALS : Findings from Vertex Pharmaceuticals Inc. Broaden Under..
04/20 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
04/16 VERTEX PHARMACEUTICALS : Data on Influenza Discussed by Researchers at Vertex Ph..
04/16 VERTEX PHARMACEUTICALS : Patent Issued for Method for Measuring ATR Inhibition M..
04/15 VERTEX PHARMACEUTICALS : to Announce First Quarter 2015 Financial Results on Apr..
04/15 NASDAQ 100 MOVERS : Vrtx, wdc
04/13 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
04/09 VERTEX PHARMACEUTICALS : to Announce First Quarter 2015 Financial Results on Apr..
04/08 VERTEX PHARMACEUTICALS : New Ulcerative Colitis Study Findings Reported from Ver..
04/08 VERTEX PHARMACEUTICALS : Researchers from Vertex Pharmaceuticals Inc. Report New..
04/06 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
04/03 VERTEX PHARMACEUTICALS : Assigned Patent
04/01 VERTEX PHARMACEUTICALS : Pronutria Biosciences™ Appoints Dr. Christopher W..
03/29 VERTEX PHARMACEUTICALS : Updates on Data from 12-Week Phase 2 Safety Study of VX..
03/29 VERTEX PHARMACEUTICALS : Secures U.S. FDA OK of KALYDECO (ivacaftor) for Childre..
03/26 VERTEX PHARMACEUTICALS : Assigned Patent
03/26 VERTEX PHARMACEUTICALS : Reports Data from 12-Week Phase 2 Safety Study of VX-66..
03/25 CHRISTOPHER WRIGHT : Pronutria Biosciences™ Appoints Dr. Christopher Wrigh..
03/25 VERTEX PHARMACEUTICALS : Patent Issued for Systems and Methods for Inline Sampli..
03/25 VERTEX PHARMACEUTICALS : Receives U.S. Food and Drug Administration Approval of ..
03/25 VERTEX PHARMACEUTICALS : Biotech Equities Technical Coverage - ZIOPHARM Oncology..
03/23 S&P 500 MOVERS : Vrtx, gnw
03/23 NASDAQ 100 MOVERS : Vrtx, vip
03/23 VERTEX PHARMACEUTICALS : Announces Data from 12-Week Phase 2 Safety Study of VX-..
03/23 VERTEX PHARMACEUTICALS : Gets U.S. FDA OK of KALYDECO (ivacaftor) for Children w..
03/18 VERTEX PHARMACEUTICALS : Researchers from Vertex Pharmaceuticals Report New Stud..
03/18 VERTEX PHARMACEUTICALS : Researchers from Vertex Pharmaceuticals Report Details ..
03/18 VERTEX PHARMACEUTICALS : Recent Findings from Vertex Pharmaceuticals Provides Ne..
03/18 VERTEX PHARMACEUTICALS : "Pharmaceutical Compositions" in Patent Application App..
03/18 VERTEX PHARMACEUTICALS : Researchers' Work from Vertex Pharmaceuticals Focuses o..
03/18 VERTEX PHARMACEUTICALS : Receives U.S. Food and Drug Administration Approval of ..
03/16 NASDAQ 100 MOVERS : Wynn, avgo
03/11 VERTEX PHARMACEUTICALS : Reports Outline Attention Deficit Hyperactivity Disorde..
03/11 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
03/11 VERTEX PHARMACEUTICALS : Patent Issued for Device to Collect and Segregate Tissu..
03/06 VERTEX PHARMACEUTICALS : Assigned Patent
03/05 Wall Street closes up slightly ahead of jobs report
03/05 NASDAQ 100 MOVERS : Aal, myl
03/05 VERTEX PHARMACEUTICALS : VRTX) is Trading Higher on Unusual Volume for March 05
03/05 VERTEX PHARMACEUTICALS : VRTX) Pops 5.76% for March 05
03/04 VERTEX PHARMACEUTICALS : Findings on Photochemistry Detailed by Investigators at..
02/26 VERTEX PHARMACEUTICALS : Researchers at Vertex Pharmaceuticals Release New Data ..
02/20 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/12 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry from Vertex Pharmac..
02/11 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08DJDrug Making Breaks Away From Its Old Ways
02/01 DEUTSCHE BANK : Vertex Pharmaceuticals PT Raised to $155.00 at Deutsche Bank (VR..
01/28 VERTEX PHARMACEUTICALS : 4Q loss is deeper than expected
01/28 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2014 Financial Res..
01/14 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/11 VERTEX PHARMACEUTICALS : Pharma Expects 2015 Kalydeco Revenues Of $560 Mln To $5..
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities to Support the Develo..
01/08 VERTEX PHARMACEUTICALS : Reports Summarize Magnetic Resonance Research Findings ..
01/08 VERTEX PHARMACEUTICALS : U.S. Food and Drug Administration Approves KALYDECO® iv..
01/08 VERTEX PHARMACEUTICALS : New Findings from Vertex Pharmaceuticals Inc. in the Ar..
01/08 VERTEX PHARMACEUTICALS : Investigators at Vertex Pharmaceuticals Inc. Discuss Fi..
01/07 VERTEX PHARMACEUTICALS : Recent Research from Vertex Pharmaceuticals Inc. Highli..
01/06 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/05 VERTEX PHARMACEUTICALS : FDA OKs Kalydeco for Use in People with Cystic Fibrosis..
01/02 S&P 500 MOVERS : Dnr, vrtx
01/01 VERTEX PHARMACEUTICALS : Investigators from Vertex Pharmaceuticals Have Reported..
2014 VERTEX PHARMACEUTICALS : Appoints David Altshuler, M.D., Ph.D. as EVP of Global ..
2014 VERTEX PHARMACEUTICALS : U.S. Food and Drug Administration Approves KALYDECO® (i..
2014 VERTEX PHARMACEUTICALS : Investigators from Vertex Pharmaceuticals Have Reported..
2014 VERTEX PHARMACEUTICALS : Appoints David Altshuler, M.D., Ph.D. as EVP of Global ..
2014 VERTEX PHARMACEUTICALS : Findings on Medicinal Chemistry Reported by Investigato..
2014 VERTEX PHARMACEUTICALS : MA : Change in Directors or Principal Officers (form 8-..
2014 VERTEX PHARMACEUTICALS : David Altshuler, M.D., Ph.D., Joins Vertex as Executive..
2014 S&P 500 MOVERS : Nbr, celg
2014 NASDAQ 100 MOVERS : Vip, celg
2014 VERTEX PHARMACEUTICALS : Patent Issued for Pyrazolopyrazine Kinase Inhibitors
2014 U.S. Patents Awarded to Inventors in Pennsylvania (Dec. 2)
2014 VERTEX PHARMACEUTICALS : Assigned Patent
1  2  3  4  5  6  7  8Next
Advertisement
Chart
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF